Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adijan Kuckovic"'
Autor:
Chike Osude, Leo Lin, Meet Patel, Adam Eckburg, Joseph Berei, Adijan Kuckovic, Namrata Dube, Aayush Rastogi, Shruti Gautam, Thomas J. Smith, Shylendra B. Sreenivassappa, Neelu Puri
Publikováno v:
Cells, Vol 11, Iss 10, p 1694 (2022)
NSCLC treatment includes targeting of EGFR with tyrosine kinase inhibitors (TKIs) such as Erlotinib; however, resistance to TKIs is commonly acquired through T790M EGFR mutations or overexpression of vascular endothelial growth factor receptor-2 (VEG
Externí odkaz:
https://doaj.org/article/aa83e90141d14f91a0783e80526c33ad
Autor:
Zachary Schrank, Nabiha Khan, Chike Osude, Sanjana Singh, Rachel J. Miller, Collin Merrick, Alexander Mabel, Adijan Kuckovic, Neelu Puri
Publikováno v:
Molecules, Vol 23, Iss 9, p 2267 (2018)
Telomeres and telomerase have become attractive targets for the development of anticancer therapeutics due to their involvement in cancer cell immortality. Currently, several therapeutics have been developed that directly target telomerase and telome
Externí odkaz:
https://doaj.org/article/f9f9853b56c64e389c88ba22c4a28964
Autor:
Marko Ivancich, Zachary Schrank, Luke Wojdyla, Brandon Leviskas, Adijan Kuckovic, Ankita Sanjali, Neelu Puri
Publikováno v:
Antioxidants, Vol 6, Iss 1, p 15 (2017)
Telomerase is expressed in more than 85% of cancer cells. Tumor cells with metastatic potential may have a high telomerase activity, allowing cells to escape from the inhibition of cell proliferation due to shortened telomeres. Human telomerase prima
Externí odkaz:
https://doaj.org/article/e647a016bf5b429485ba44109f0716c8
Autor:
Neelu Puri, Collin Merrick, Chike Osude, Rachel J. Miller, Sanjana Singh, Nabiha Khan, Adijan Kuckovic, Alexander Mabel, Zachary Schrank
Publikováno v:
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 23, Iss 9, p 2267 (2018)
Molecules, Vol 23, Iss 9, p 2267 (2018)
Telomeres and telomerase have become attractive targets for the development of anticancer therapeutics due to their involvement in cancer cell immortality. Currently, several therapeutics have been developed that directly target telomerase and telome
Autor:
Ankita Sanjali, Adijan Kuckovic, Marko Ivancich, Brandon Leviskas, Luke Wojdyla, Zachary Schrank, Neelu Puri
Publikováno v:
Antioxidants, Vol 6, Iss 1, p 15 (2017)
Antioxidants
Antioxidants
Telomerase is expressed in more than 85% of cancer cells. Tumor cells with metastatic potential may have a high telomerase activity, allowing cells to escape from the inhibition of cell proliferation due to shortened telomeres. Human telomerase prima
Autor:
Joseph Ross, Joseph Berei, Connie Vitali, Shylendra Sreenivasappa, William Schulz, Neelu Puri, Sandra Martell, Adijan Kuckovic
Publikováno v:
Cancer Research. 79:3329-3329
In lung cancer, 81% of patients detected are late-stage, since early-stage patients are generally asymptomatic. Winnebago County has a 14% higher mortality rate for lung cancer when compared to the national rate; hence, to improve early detection of
Autor:
Zachary Schrank, Nabiha Khan, Lin Leo S, Gagan Chhabra, Rachel J. Miller, Adijan Kuckovic, Neelu Puri, Sanjana Singh, Chike Osude, Tsatsral Iderzorig
Publikováno v:
Cancers
Cancers, Vol 10, Iss 7, p 224 (2018)
Cancers, Vol 10, Iss 7, p 224 (2018)
Lung cancer is treated with many conventional therapies, such as surgery, radiation, and chemotherapy. However, these therapies have multiple undesirable side effects. To bypass the side effects elicited by these conventional treatments, molecularly-